Asset Details
Do you wish to reserve the book?
Pharmacogenetics of methotrexate response in rheumatoid arthritis: an update
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Pharmacogenetics of methotrexate response in rheumatoid arthritis: an update
Do you wish to request the book?
Pharmacogenetics of methotrexate response in rheumatoid arthritis: an update
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Pharmacogenetics of methotrexate response in rheumatoid arthritis: an update
2020
Overview
[...]it is vital that baseline characteristics predictive of response to MTX are discovered to prevent long-term disability. The DAS28 is a weighted score of the number of tender and swollen joints out of 28, the patient’s global assessment of arthritis activity on a visual analog scale (VAS, 0-100mm) and a biochemical maker of inflammation (erythrocyte sedimentation rate, ESR or C-reactive protein, CRP). [...]predicting MTX response and developing stratified medicine techniques is vital. [...]there is variation in treatment outcome measures between studies and most utilize the DAS28, which includes subjective patient-reported outcome measures (TJC, VAS), as previously discussed.
Publisher
Future Medicine Ltd
Subject
Antirheumatic Agents - adverse effects
/ Antirheumatic Agents - therapeutic use
/ Arthritis, Rheumatoid - drug therapy
/ Arthritis, Rheumatoid - genetics
/ Disease
/ DMARD
/ Erythrocyte sedimentation rate
/ genetics
/ Genomes
/ Humans
/ Methotrexate - adverse effects
/ Methotrexate - therapeutic use
/ Patients
/ Studies
